Nectar Lifesciences informs about closure of trading window

27 Jun 2025 Evaluate

With reference to the Company’s earlier communication No. NLL/CS/2025/-471 dated March 26, 2025, on ‘Closure of Trading Window’ effective April 1, 2025, in terms of the Code of Conduct as per Regulation 9 of SEBI (Prohibition of Insider Trading) Regulations, 2015. In this regard, Nectar Lifesciences has informed that the trading window for dealing in securities of the Company shall continue to remain closed for the designated persons and their immediate relatives till the declaration of audited financial results of the Company for the quarter and year ended March 31, 2025 as well as from July 01, 2025, till 48 hours after the declaration of unaudited financial results for quarter ended June 30, 2025. The date of the Board Meeting of the Company for declaration of audited financial results of the Company for the quarter and year ended March 31, 2025, and/or unaudited financial results for quarter ended June 30, 2025, will be intimated in due course. Accordingly, Designated Persons and their immediate relatives are advised not to trade in the securities of the Company during the aforesaid period of Closure of Trading Window.

The above information is a part of company’s filings submitted to BSE.

Nectar Lifesciences Share Price

20.95 0.01 (0.05%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×